ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Neoplasm Metastasis
Ovarian Cancer

Breast Cancer trials near Birmingham, AL, USA:

Olaparib in Metastatic Breast Cancer

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Birmingham, Alabama, United States and 19 other locations

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Active, not recruiting
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

SCRI Development Innovations

Birmingham, Alabama, United States and 10 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Birmingham, Alabama, United States and 9 other locations

and Lapatinib, given to participants with metastatic triple negative breast cancer that have undergone previous treatment. Velipari ...

Active, not recruiting
Metastatic Triple Negative Breast Cancer
Drug: Combination of Veliparib + Lapatinib
The University of Alabama at Birmingham
The University of Alabama at Birmingham

Birmingham, Alabama, United States

and TRC105) is tolerated and how well it works in Stage 2 and 3 breast cancer when given prior to definitive surgery. Letrozole blo ...

Active, not recruiting
Breast Cancer
Drug: TRC105
Drug: Letrozole

Phase 1, Phase 2

The University of Alabama at Birmingham
The University of Alabama at Birmingham

Birmingham, Alabama, United States

This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...

Active, not recruiting
Breast Cancer
Drug: Utomilumab
Drug: Vinorelbine

Phase 2

Adrienne G. Waks

Birmingham, Alabama, United States and 16 other locations

together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: trastuzumab deruxtecan
Drug: tucatinib

Phase 2

Seagen
Seagen

Birmingham, Alabama, United States and 32 other locations

The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers ...

Enrolling
HER2 Positive Breast Carcinoma
Metastatic Breast Cancer
Drug: Trastuzumab
Drug: Niraparib

Phase 1, Phase 2

The University of Alabama at Birmingham
The University of Alabama at Birmingham

Birmingham, Alabama, United States and 6 other locations

with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...

Enrolling
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Drug: Alisertib
Drug: Endocrine therapy

Phase 2

Puma Biotechnology
Puma Biotechnology

Birmingham, Alabama, United States of America and 13 other locations

Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...

Enrolling
Breast Cancer
Breast Carcinoma in Situ
Other: Screening advice based on a basic risk assessment
Other: Complete a health questionnaire
University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

Birmingham, Alabama, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems